Basic Information
| RNALocate ID: | RLID-D:11000562 |
| RNA Symbol: | hsa-miR-766-3p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-766-3p |
| RNA ID: | miRBase:MIMAT0003888 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Fibroblasts|Mesenchymal stem cells |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002544 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:11003527 | Exosome | Plasma | 23663360 |
| RLID:11003528 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11003529 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11001437 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-766-3p | Medulloblastoma | MNDR-E-MI-69061 |
| MNDR | hsa-miR-766-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-69062 |
| MNDR | hsa-miR-766-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-69063 |
| MNDR | hsa-miR-766-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-69064 |
| MNDR | hsa-miR-766-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-69065 |
| MNDR | hsa-miR-766-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-69066 |
| MNDR | hsa-miR-766-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-69067 |
| MNDR | hsa-miR-766-3p | Her2-receptor positive breast cancer | MNDR-E-MI-69068 |
| MNDR | hsa-miR-766-3p | Prostate cancer | MNDR-E-MI-69069 |
| MNDR | hsa-miR-766-3p | Gastric cancer | MNDR-E-MI-69070 |
| MNDR | hsa-miR-766-3p | Alzheimer disease | MNDR-E-MI-69071 |
| MNDR | hsa-miR-766-3p | Polycystic ovary syndrome | MNDR-E-MI-69072 |
| MNDR | hsa-miR-766-3p | Head and neck cancer | MNDR-E-MI-69073 |
| MNDR | hsa-miR-766-3p | Leukemia | MNDR-E-MI-69074 |
| MNDR | hsa-miR-766-3p | Cardiovascular disease | MNDR-E-MI-69075 |
| MNDR | hsa-miR-766-3p | Lung cancer | MNDR-E-MI-69076 |
| MNDR | hsa-miR-766-3p | Parkinson disease | MNDR-E-MI-69077 |
| MNDR | hsa-miR-766-3p | Breast cancer | MNDR-E-MI-69078 |
| MNDR | hsa-miR-766-3p | Pancreatic cancer | MNDR-E-MI-69079 |
| MNDR | hsa-miR-766-3p | Melanoma | MNDR-E-MI-69080 |
| MNDR | hsa-miR-766-3p | Rectum adenocarcinoma | MNDR-E-MI-69081 |
| MNDR | hsa-miR-766-3p | Nephroblastoma | MNDR-E-MI-69082 |
| MNDR | hsa-miR-766-3p | Colon cancer | MNDR-E-MI-69083 |
| MNDR | hsa-miR-766-3p | Colon adenocarcinoma | MNDR-E-MI-69084 |
| MNDR | hsa-miR-766-3p | Ovarian cancer | MNDR-E-MI-69085 |
| MNDR | hsa-miR-766-3p | Prostate adenocarcinoma | MNDR-E-MI-69086 |
| MNDR | hsa-miR-766-3p | Carcinoma ductal breast | MNDR-E-MI-69087 |
| MNDR | hsa-miR-766-3p | Glioma | MNDR-E-MI-69088 |
| MNDR | hsa-miR-766-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-69089 |
| MNDR | hsa-miR-766-3p | Osteosarcoma | MNDR-E-MI-69090 |
| MNDR | hsa-miR-766-3p | Gastric adenocarcinoma | MNDR-E-MI-69091 |
| MNDR | hsa-miR-766-3p | Lung squamous cell carcinoma | MNDR-E-MI-69092 |
| MNDR | hsa-miR-766-3p | Adrenocortical cancer | MNDR-E-MI-69093 |
| MNDR | hsa-miR-766-3p | Ovarian carcinoma | MNDR-E-MI-69094 |
| MNDR | hsa-miR-766-3p | Bladder urothelial carcinoma | MNDR-E-MI-69095 |
| MNDR | hsa-miR-766-3p | Pancreatic adenocarcinoma | MNDR-E-MI-69096 |
| MNDR | hsa-miR-766-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-69097 |
| MNDR | hsa-miR-766-3p | Carcinoma renal cell | MNDR-E-MI-69098 |
| MNDR | hsa-miR-766-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-69099 |
| MNDR | hsa-miR-766-3p | Renal clear cell carcinoma | MNDR-E-MI-69100 |
| MNDR | hsa-miR-766-3p | Large cell carcinoma | MNDR-E-MI-69101 |
| MNDR | hsa-miR-766-3p | Cholangiocarcinoma | MNDR-E-MI-69102 |
| MNDR | hsa-miR-766-3p | Esophageal cancer | MNDR-E-MI-69103 |
| MNDR | hsa-miR-766-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-69104 |
| MNDR | hsa-miR-766-3p | T acute lymphoblastic leukemia | MNDR-E-MI-69105 |
| MNDR | hsa-miR-766-3p | Acute t cell leukemia | MNDR-E-MI-69106 |
| MNDR | hsa-miR-766-3p | Breast invasive carcinoma | MNDR-E-MI-69107 |
| MNDR | hsa-miR-766-3p | Hepatocellular carcinoma | MNDR-E-MI-69108 |
| MNDR | hsa-miR-766-3p | Malignant pleural mesothelioma | MNDR-E-MI-69109 |
| MNDR | hsa-miR-766-3p | Retinoblastoma | MNDR-E-MI-69110 |
| MNDR | hsa-miR-766-3p | Barrett's adenocarcinoma | MNDR-E-MI-69111 |
| MNDR | hsa-miR-766-3p | Neuromyelitis optica | MNDR-E-MI-69112 |
| MNDR | hsa-miR-766-3p | Skin cutaneous melanoma | MNDR-E-MI-69113 |
| MNDR | hsa-miR-766-3p | Skin melanoma | MNDR-E-MI-69114 |
| MNDR | hsa-miR-766-3p | Colorectal cancer | MNDR-E-MI-69115 |
| MNDR | hsa-miR-766-3p | Nasopharynx carcinoma | MNDR-E-MI-69116 |
| MNDR | hsa-miR-766-3p | Nasopharyngeal cancer | MNDR-E-MI-69117 |
| MNDR | hsa-miR-766-3p | Cerebral hemorrhage traumatic | MNDR-E-MI-69118 |
| MNDR | hsa-miR-766-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-69119 |
| MNDR | hsa-miR-766-3p | Barrett's carcinogenesis | MNDR-E-MI-69120 |
| MNDR | hsa-miR-766-3p | Breast cancer her3+ negative | MNDR-E-MI-69121 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCG1 | Homo sapiens | RR00024647 |
TOP